Biphasic dissolution as an exploratory method during early drug product development (2020)
Silva, Daniela Amaral; Gousous, Jozef Al; Davies, Neal M; Bou-Chacra, Nadia Araci 
; Webster, Gregory K; Lipka, Elke; Amidon, Gordon L; Löbenberg, Raimar
Source: Pharmaceutics. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, v. 12, p. 1-17 art, 2020Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics12050420. Acesso em: 15 ago. 2024.APA
Silva, D. A., Gousous, J. A., Davies, N. M., Bou-Chacra, N. A., Webster, G. K., Lipka, E., et al. (2020). Biphasic dissolution as an exploratory method during early drug product development. Pharmaceutics, 12, 1-17 art. doi:10.3390/pharmaceutics12050420NLM
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 ago. 15 ] Available from: https://doi.org/10.3390/pharmaceutics12050420Vancouver
Silva DA, Gousous JA, Davies NM, Bou-Chacra NA, Webster GK, Lipka E, Amidon GL, Löbenberg R. Biphasic dissolution as an exploratory method during early drug product development [Internet]. Pharmaceutics. 2020 ; 12 1-17 art.[citado 2024 ago. 15 ] Available from: https://doi.org/10.3390/pharmaceutics12050420
